Screener
Mirum Pharmaceuticals, Inc. MIRM Accounts Receivable
Accounts Receivable at other companies
Other financials
Where this comes from
Reported directly by Mirum Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:AccountsReceivableNetCurrent.
The source filing: Mirum Pharmaceuticals, Inc.’s 10-Q, filed August 5, 2026. Open the filing →
- Filed
- Aug 5, 2026, 4:06 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001759425-26-000045
FAQ
- What is Mirum Pharmaceuticals, Inc.'s accounts receivable?
- Mirum Pharmaceuticals, Inc. (MIRM) reported accounts receivable of $145.36M in Q2 2026.
- How has Mirum Pharmaceuticals, Inc.'s accounts receivable changed year-over-year?
- Mirum Pharmaceuticals, Inc.'s accounts receivable increased by 36.1% year-over-year, from $106.84M to $145.36M.
- What does accounts receivable mean?
- Amounts owed by customers for goods delivered or services performed, net of allowances for doubtful accounts. A key working capital component.
Ask your AI about Mirum Pharmaceuticals, Inc.'s accounts receivable.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude